After price deal, Takeda’s lung cancer drug Exkivity wins UK green light ahead of J&J rival

After price deal, Takeda’s lung cancer drug Exkivity wins UK green light ahead of J&J rival
kdunleavy
Mon, 03/21/2022 – 12:33